Beginning Cash: The amount of cash reported by the company on its previous statement.
Krystal Biotech, Inc. (KRYS) had Beginning Cash of $496.30M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$116.36M |
|
$55.93M |
|
$6.32M |
|
$110.03M |
|
$62.67M |
|
$53.69M |
|
$7.75M |
|
$61.44M |
|
$61.44M |
|
$55.93M |
|
$55.93M |
|
$55.93M |
|
$55.93M |
|
$53.69M |
|
$55.41M |
|
29.29M |
|
30.51M |
|
$1.91 |
|
$1.83 |
|
| Balance Sheet Financials | |
$1.02B |
|
$153.58M |
|
$377.23M |
|
$1.40B |
|
$107.80M |
|
-- |
|
$12.44M |
|
$120.24M |
|
$1.28B |
|
$1.28B |
|
$1.28B |
|
29.44M |
|
| Cash Flow Statement Financials | |
$80.38M |
|
$-63.58M |
|
$-10.46M |
|
|
Beginning Cash |
$496.30M |
$501.31M |
|
$5.01M |
|
$13.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.46 |
|
-- |
|
-- |
|
-- |
|
-- |
|
94.57% |
|
46.14% |
|
46.14% |
|
-- |
|
52.80% |
|
48.07% |
|
$73.23M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.15 |
|
0.92 |
|
98.25 |
|
4.38% |
|
4.38% |
|
4.00% |
|
4.38% |
|
$43.37 |
|
$2.40 |
|
$2.63 |
|